Full Name
Vasudevan Subhash
Variants
Vasudevan, S.G.
Vasudevan, S.
 
Main Affiliation
 
 
Email
gmsvsg@nus.edu.sg
 

Publications

Results 1-20 of 62 (Search time: 0.013 seconds).

Issue DateTitleAuthor(s)
11-Jan-202118F-fluorodeoxyglucose positron emission tomography as a window into human dengue pathophysiologyKalimuddin, Shirin ; Xie, Wanying; Watanabe, Satoru ; Tham, Jing Yang ; Sam, Huizhen; Chan, Kitti Wing Ki ; Yap, Tiang Siew; Totman, John J. ; Chacko, Ann-Marie ; Vasudevan, Subhash G. ; Low, Jenny G. 
22015A Crystal Structure of the Dengue Virus NS5 Protein Reveals a Novel Inter-domain Interface Essential for Protein Flexibility and Virus ReplicationZhao Y.; Soh T.S.; Zheng J.; Chan K.W.K.; Phoo W.W.; Lee C.C.; Tay M.Y.F.; Swaminathan K. ; Cornvik T.C.; Lim S.P.; Shi P.-Y.; Lescar J.; Vasudevan S.G. ; Luo D.
33-Apr-2012A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoproteinChan, A.H.Y.; Tan, H.C.; Chow, A.Y.; Lim, A.P.C.; Lok, S.M.; Moreland, N.J.; Vasudevan, S.G. ; MacAry, P.A.; Ooi, E.E.; Hanson, B.J.
4Oct-2010A method for full genome sequencing of all four serotypes of the dengue virusChristenbury, J.G.; Aw, P.P.K.; Ong, S.H.; Schreiber, M.J.; Chow, A.; Gubler, D.J. ; Vasudevan, S.G. ; Ooi, E.E.; Hibberd, M.L.
52020A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue VaccineChoy, M.M.; Ng, D.H.L.; Siriphanitchakorn, T.; Ng, W.C.; Sundstrom, K.B.; Tan, H.C.; Zhang, S.L.; Chan, K.W.K.; Manuel, M.; Kini, R.M. ; Chan, K.R.; Vasudevan, S.G. ; Ooi, E.E. 
6May-2009A small-molecule dengue virus entry inhibitorWang, Q.-Y.; Patel, S.J.; Vangrevelinghe, E.; Hao, Y.X.; Rao, R.; Jaber, D.; Schul, W.; Gu, F.; Heudi, O.; Ngai, L.M.; Mee, K.P.; Wai, Y.P.; Keller, T.H.; Jacoby, E.; Vasudevan, S.G. 
72018A systematic approach to the development of a safe live attenuated Zika vaccineKwek, S.S; Watanabe, S ; Chan, K.R ; Ong, E.Z ; Tan, H.C ; Ng, W.C ; Nguyen, M.T.X ; Gan, E.S ; Zhang, S.L ; Chan, K.W.K ; Tan, J.H ; Sessions, O.M ; Manuel, M; Pompon, J ; Chua, C; Hazirah, S; Tryggvason, K ; Vasudevan, S.G ; Ooi, E.E 
826-Jun-2019A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in miceChan, Kitti Wing Ki; Watanabe, Satoru; Jin, Jocelyn Y; Pompon, Julien; Teng, Don; Alonso, Sylvie ; Vijaykrishna, Dhanasekaran ; Halstead, Scott B; Marzinek, Jan K ; Bond, Peter J ; Burla, Bo ; Torta, Federico; Wenk, Markus R ; Ooi, Eng Eong ; Vasudevan, Subhash G 
915-Nov-2021Amidoxime prodrugs convert to potent cell-active multimodal inhibitors of the dengue virus proteaseCRYSTALL MARIE DAWN SWARBRICK ; Vasiliki Zogali; Chan Wing Ki Kitti ; Dimitrios Kiousis; GWEE CHIN PIAW ; WANG SAI ; Julien Lescar; Dahai Luo; Mark von Itzstein; Minos-Timotheos Matsoukas; George Panagiotakopoulos; Vasudevan, S.G. ; Gerasimos Rassias
107-May-2019Assessing the Utility of Antivirals for Preventing Maternal-Fetal Transmission of Zika Virus in pregnant miceSATORU WATANABE ; TAN WEI WEN ; Chan Wing Ki Kitti ; Vasudevan, S.G. 
11Dec-2011Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse modelRathore, A.P.S. ; Paradkar, P.N.; Watanabe, S.; Tan, K.H.; Sung, C.; Connolly, J.E.; Low, J.; Ooi, E.E.; Vasudevan, S.G. 
122016Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus ReplicationSuzuki Y.; Chin W.-X.; Han Q.; Ichiyama K.; Lee C.H.; Eyo Z.W.; Ebina H.; Takahashi H.; Takahashi C.; Tan B.H.; Hishiki T.; Ohba K.; Matsuyama T.; Koyanagi Y.; Tan Y.-J. ; Sawasaki T.; Chu J.J.H. ; Vasudevan S.G. ; Sano K.; Yamamoto N.
13Mar-2014Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivoRathore, A.P.S. ; Haystead, T.; Das, P.K.; Merits, A.; Ng, M.-L.; Vasudevan, S.G. 
142015Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsificationKoh V. ; Tatsios J. ; Chew P.T.K. ; Amrith S.
152008Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illnessTanner L.; Schreiber M.; Low J.G.H.; Ong A.; Tolfvenstam T.; Lai Y.L.; Ng L.C.; Leo Y.S.; Puong L.T.; Vasudevan S.G. ; Simmons C.P.; Hibberd M.L.; Ooi E.E. 
16Oct-2011Dengue protease activity: The structural integrity and interaction of NS2B with NS3 protease and its potential as a drug targetPhong, W.Y.; Moreland, N.J.; Lim, S.P.; Wen, D.; Paradkar, P.N.; Vasudevan, S.G. 
172007Dengue virus serotype infection specifies the activation of the unfolded protein responseUmareddy I.; Pluquet O.; Wang Q.Y.; Vasudevan S.G. ; Chevet E.; Gu F.
18Oct-2009Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus controlFink, K.; Ng, C.; Nkenfou, C.; Vasudevan, S.G. ; Van Rooijen, N.; Schul, W.
192013Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2α phosphorylationRathore, A.P.S. ; Ng, M.-L.; Vasudevan, S.G. 
20Oct-2012Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trialWatanabe, S.; Rathore, A.P.S. ; Sung, C.; Lu, F.; Khoo, Y.M.; Connolly, J.; Low, J.; Ooi, E.E.; Lee, H.S.; Vasudevan, S.G.